A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumor growth and blocking off the escape routes it uses to become resistant to treatment, finds a new study.
A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumor growth and blocking off the escape routes it uses to become resistant to treatment, finds a new study.